The National institute on Drug Abuse (NIDA), part of the National Institutes of Health, will present a full day symposium on the epidemiology of stimulant abuse and treatment as part of the 38th Annual Medical-Scientific Conference of the American Society of Addiction Medicine (ASAM).
Led by NIDA Deputy Director Dr. Timothy P. Condon, NIDA experts will discuss the behavioral approaches that are currently the mainstay of treatment, the most recent studies involving contingency management techniques, and pharmacotherapeutic studies of marketed medications for the management of cocaine and methamphetamine dependence.
Abuse of stimulants continues to be a major public health problem in the United States. Neuroscience is uncovering new directions for medical therapies.
When:
Friday, April 27, 2007: Dr. Condon at Plenary (9:00 a.m.)
Saturday April 28, 2007
10:00 a.m. ? 12 Noon
2:00 ? 4:00 p.m.
Where:
Marriott Doral Resort and Spa
Miami, Florida
Featured Speakers from NIDA:
Dr. Timothy P. Condon, Deputy Director, NIDA
Dr. Frank Vocci, Director, Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
Dr. Ahmed Elkashef, Chief of the Clinical Medical Branch, DPMCDA
Dr. Wilson Compton, Director, Division of Epidemiology, Services and Prevention Research (DESPR)
Other Featured Speakers:
Dr. Kyle Kampman and Dr. Charles Dackis,
University of Pennsylvania; Dr. Kathleen Brady, Medical University of South Carolina;
Dr. Nancy Petry, University of Connecticut School of Medicine; Dr. Walter Ling, UCLA School of Medicine